Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Cesarean Myomectomy
NCT03505502Completed
- Sponsor
- Aswan University Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in hemorrhage (3 arms), sponsored by Aswan University Hospital. Primary endpoint: Estimation of Intraoperative Blood Loss. Started Jan 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03505502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03505502.